Free Trial

PROCEPT BioRobotics Q4 2022 Earnings Report

PROCEPT BioRobotics logo
$76.02 -2.82 (-3.58%)
As of 01/17/2025 04:00 PM Eastern

PROCEPT BioRobotics EPS Results

Actual EPS
-$0.56
Consensus EPS
-$0.53
Beat/Miss
Missed by -$0.03
One Year Ago EPS
N/A

PROCEPT BioRobotics Revenue Results

Actual Revenue
$23.78 million
Expected Revenue
$23.70 million
Beat/Miss
Beat by +$80.00 thousand
YoY Revenue Growth
N/A

PROCEPT BioRobotics Announcement Details

Quarter
Q4 2022
Time
N/A

Conference Call Resources

Conference Call Audio

Slide Deck

PROCEPT BioRobotics Earnings Headlines

Spruce Point Capital says short Procept BioRobotics
Boomers miss Bitcoin rally
Eric's been mining Bitcoin since 2013... and has helped ordinary Americans achieve incredible gains on cryptos like Frontier, which soared 979% in just 5 weeks. Today, Eric has found a smaller crypto that he believes could be even more profitable for investors than Bitcoin.
PROCEPT BioRobotics
See More PROCEPT BioRobotics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like PROCEPT BioRobotics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PROCEPT BioRobotics and other key companies, straight to your email.

About PROCEPT BioRobotics

PROCEPT BioRobotics (NASDAQ:PRCT), a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

View PROCEPT BioRobotics Profile

More Earnings Resources from MarketBeat